Abstract:Objective To analyze the clinical effect of antiviral therapy in hepatitis B cirrhosis.Methods According to the randomized method,60 patients with hepatitis B cirrhosis were diagnosed and treated in our hospital from February 2015 to March 2017.They were equally divided into control group and observation group,30 cases in each group.In the control group,routine symptomatic treatment and Lamivudine were used,while in the observation group,Lamivudine Plus combined with Adefovir Dipivoxil as antiviral therapy was adopted.The effect of the two groups were compared.Results The total effectiveness rate of hepatitis B liver cirrhosis in the observation group was significantly higher than that of the control group (P<0.05).The Child-Pugh score and prothrombin activity in the observation group were significantly higher than those in the control group (P<0.05).HBV-DNA in the observation group was significantly lower than that in the control group (P<0.05).There was no significant difference between the two groups before the intervention of PCⅢ,IVC,LN,or HA (P>0.05).The changes of differences in liver fibrosis indexes such as PCⅢ,IVC,LN,and HA in the observation group were significantly lower than those in the control group after intervention (P<0.05).Besides,the changes of these indexes above-mentioned in the two groups after intervention were significantly lower than those before intervention,which were displayed statistical significance (P<0.05).Conclusion Lamivudine combined with Adefovir Dipivoxil as anti-virus is effective in the treatment of hepatitis B cirrhosis.The clinical effect is reliable.It can remarkably alleviate the hepatic fibrosis,increase the activity of prothrombin,and reduce HBV-DNA.
李国斌;黄容旺;魏娣;陈铭. 拉米夫定联合阿德福韦酯抗病毒治疗在乙肝肝硬化患者中的应用效果[J]. 中国当代医药, 2018, 25(20): 43-45.
LI Guo-bin;HUANG Rong-wang;WEI Di;CHEN Ming. Application effect of antiviral therapy with Lamivudine combined with Adefovir Dipivoxil in patients with hepatitis B cirrhosis. 中国当代医药, 2018, 25(20): 43-45.